Osteoprotegerin, but not osteopontin, as a potential predictor of vascular calcification in normotensive subjects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Osteoprotegerin, but not osteopontin, as a potential predictor of vascular calcification in normotensive subjects

Published:2012-01-26 Issue:5 Volume:35 Page:531-538
ISSN:0916-9636
Container-title:Hypertension Research
language:en
Short-container-title:Hypertens Res

Author:

Stępień Ewa,Fedak Danuta,Klimeczek Piotr,Wilkosz Tadeusz,Banyś Robert Paweł,Starzyk Katarzyna,Bazanek Marta,Pasowicz Mieczysław

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Link

http://www.nature.com/articles/hr2011231.pdf

Reference38 articles.

1. Waluś-Miarka M, Katra B, Fedak D, Czarnecka D, Miarka P, Woźniakiewicz E, Małecki M, Idzior-Waluś B . Osteoprotegerin is associated with markers of atherosclerosis and body fat mass in type 2 diabetes patients. Int J Cardiol 2011; 147: 335–336.

2. Jono S, Ikari Y, Shioi A, Mori K, Miki T, Hara K, Nishizawa Y . Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation 2002; 106: 1192–1194.

3. Siepi D, Marchesi S, Vaudo G, Lupattelli G, Bagaglia F, Pirro M, Brozzetti M, Roscini AR, Mannarino E . Preclinical vascular damage in white postmenopausal women: the relevance of osteoprotegerin. Metabolism 2008; 57: 321–325.

4. Georgiadou P, Iliodromitis EK, Kolokathis F, Varounis C, Gizas V, Mavroidis M, Capetanaki Y, Boudoulas H, Kremastinos DT . Osteopontin as a novel prognostic marker in stable ischaemic heart disease: a 3-year follow-up study. Eur J Clin Invest 2010; 40: 288–293.

5. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle WJ . Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 1999; 96: 3540–3545.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Osteopontin in Atherosclerosis and Its Clinical Manifestations (Atherosclerotic Cardiovascular Diseases)—A Narrative Review;Biomedicines;2023-11-29

2. Serum biomarkers for arterial calcification in humans: A systematic review;Bone Reports;2022-12

3. The association of plasma osteoprotegerin levels and functional outcomes post endovascular thrombectomy in acute ischemic stroke patients: a retrospective observational study;PeerJ;2022-05-03

4. Liver Fat Is Associated With Markers of Inflammation and Oxidative Stress in Analysis of Data From the Framingham Heart Study;Clinical Gastroenterology and Hepatology;2019-05

5. Osteoprotegerin levels are associated with liver fat and liver markers in dysmetabolic adults;Diabetes & Metabolism;2016-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3